Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Pearse

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Transplantation|July 17, 1998
Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejectionP J Cowan, C G Chen, T A Shinkel, et al.
Xenotransplantation|November 18, 2000
Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout miceH Gock, E Salvaris, L Murray-Segal, et al.
Transplantation|April 16, 1998
High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejectionP J Cowan, C A Somerville, T A Shinkel, et al.
Xenotransplantation|December 16, 1998
High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 aloneP J Cowan, T A Shinkel, A Aminian, et al.
Transplantation|October 15, 1998
Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejectionM J Pearse, E Witort, P Mottram, et al.
Transplantation|February 27, 1996
Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attackB J van Denderen, M J Pearse, M Katerelos, et al.
Clinical & Developmental Immunology|September 26, 2013
Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccinationB J Sedgmen, L Papalia, L Wang, et al.
Transplantation|July 26, 2000
Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboonsP J Cowan, A Aminian, H Barlow, et al.
Transplantation|January 15, 1996
The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantationR G Tearle, M J Tange, Z L Zannettino, et al.
Transgenic Research|January 31, 2002
Effect of DNA concentration on transgenesis rates in mice and pigsM B Nottle, K A Haskard, P J Verma, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Transplantation|July 17, 1998
Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejectionP J Cowan, C G Chen, T A Shinkel, et al.
Xenotransplantation|November 18, 2000
Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout miceH Gock, E Salvaris, L Murray-Segal, et al.
Transplantation|April 16, 1998
High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejectionP J Cowan, C A Somerville, T A Shinkel, et al.
Xenotransplantation|December 16, 1998
High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 aloneP J Cowan, T A Shinkel, A Aminian, et al.
Transplantation|October 15, 1998
Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejectionM J Pearse, E Witort, P Mottram, et al.
Transplantation|February 27, 1996
Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attackB J van Denderen, M J Pearse, M Katerelos, et al.
Clinical & Developmental Immunology|September 26, 2013
Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccinationB J Sedgmen, L Papalia, L Wang, et al.
Transplantation|July 26, 2000
Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboonsP J Cowan, A Aminian, H Barlow, et al.
Transplantation|January 15, 1996
The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantationR G Tearle, M J Tange, Z L Zannettino, et al.
Transgenic Research|January 31, 2002
Effect of DNA concentration on transgenesis rates in mice and pigsM B Nottle, K A Haskard, P J Verma, et al.
Pageof 4